Some early breast cancer patients can safely avoid certain surgeries. That's according to two studies published Thursday that ...

A "watch-and-wait" strategy might be the best option for some women with early-stage, low-risk breast cancer.

The first study comparing surgery to active monitoring as treatment for ductal carcinoma in situ (DCIS) finds women who carefully monitor the precancerous cells are no more likely to develop breast ...

Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, ...

For patients with ductal carcinoma in situ (DCIS), active monitoring (AM) is noninferior to guideline-concordant care (GCC) ...

Among patients with hormone receptor (HR)-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS), those who ...

Watching and waiting is a safe and viable treatment option for many women with DCIS breast cancer, a new study finds.Researchers say patients with low-risk duct ...

Researchers examined pooled data from two clinical trials that enrolled patients with low- or intermediate-grade ductal ...

Two recent studies explore options for early-stage breast cancer patients to reduce surgery. One suggests active monitoring ...

In this prespecified secondary analysis of the Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET ...

Women with low-risk ductal carcinoma in situ randomized to active monitoring did not have a higher rate of invasive cancer in the same breast at 2 years compared with those randomized to ...

The research, published in JAMA, suggests that active monitoring could be a viable alternative to surgery and radiation for low-risk patients with ductal carcinoma in situ (DCIS), known as stage zero ...